26Indexed trials
mesh condition
Neurocognitive Disorders
Intelligence
Neurocognitive Disorders intelligence: 26 indexed trials, 10 recruiting studies, 25 sponsors across 33 countries.
10Recruiting
25Sponsors
33Countries
Leading sponsors
University of Michigan21 recruiting
Eastern Virginia Medical School11 recruiting
Hospices Civils de Lyon10 recruiting
Elizabeth K Rhodus10 recruiting
Genentech, Inc.10 recruiting
Hoffmann-La Roche10 recruiting
Eli Lilly and Company11 recruiting
Inmune Bio, Inc.10 recruiting
MapLight Therapeutics11 recruiting
National Center of Neurology and Psychiatry, Japan10 recruiting
National Institutes of Health Clinical Center (CC)10 recruiting
Assistance Publique - Hôpitaux de Paris11 recruiting
Geographic activity
United States12trials
France8trials
Poland4trials
Canada4trials
Italy4trials
Spain4trials
United Kingdom3trials
Portugal3trials
Germany3trials
Australia3trials
South Korea3trials
Czechia2trials
Leading interventions
Amyloid PET CT1trials
BPN147701trials
Blood sampling1trials
Blood tests1trials
Breast milk sampling1trials
Caffeine citrate1trials
Crenezumab1trials
Dextrose Water1trials
Digital intervention1trials
Donanemab1trials
Drug: [18F]florbetaben1trials
Amniotic fluid sampling1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.